Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Very scanty evidence is available on factors influencing the choice of immunosuppressive drug therapy after kidney transplantation. Methods: An Italian multiregional real-world study was conducted integrating national transplant information system and claims data. All patients undergoing kidney transplantation for the first time during 2009–2019 (incident patients) were considered. Multilevel logistic models were used to estimate Odds Ratio (OR) and corresponding 95% Confidence intervals. Factors with statistically significance were identified as characteristics associated with treatment regimens: cyclosporin-CsA vs tacrolimus-Tac and, within the latter group, mTOR inhibitors vs mycophenolate-MMF. Results: We identified 3,622 kidney patients undergoing transplantation in 17 hospitals located in 4 Italian regions, 78.3% was treated with TAC-based therapy, of which 78% and 22% in combination with MMF and mTOR, respectively. For both comparison groups, the choice of immunosuppressive regimens was mostly guided by standard hospital practices. Only few recipient and donor characteristics were found associated with specific regimen (donor/receipt age, immunological risk and diabetes). Conclusions: The choice of post-renal transplant immunosuppressive therapy seems to be mostly driven by standard Centre practices, while only partially based on patient’s characteristics and recognized international guidelines.

References Powered by Scopus

Appropriate assessment of neighborhood effects on individual health: Integrating random and fixed effects in multilevel logistic regression

752Citations
N/AReaders
Get full text

KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary

592Citations
N/AReaders
Get full text

Receiver operating characteristic curve: overview and practical use for clinicians

510Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Synergistic antifungal activity against Candida albicans between voriconazole and cyclosporine a loaded in polymeric nanoparticles

0Citations
N/AReaders
Get full text

Terapia immunosoppressiva di mantenimento nei pazienti sottoposti a trapianto di organo solido: survey delle esperienze dai centri-trapianto italiani

0Citations
N/AReaders
Get full text

HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Rosa, A. C., Finocchietti, M., Agabiti, N., Menè, P., Bracaccia, M. E., Bellini, A., … Belleudi, V. (2023). Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project). BMC Nephrology, 24(1). https://doi.org/10.1186/s12882-023-03325-9

Readers over time

‘23‘2401234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Readers' Discipline

Tooltip

Nursing and Health Professions 1

100%

Article Metrics

Tooltip
Mentions
News Mentions: 2

Save time finding and organizing research with Mendeley

Sign up for free
0